CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities NGS Genetic DNA Test
Introduction
The CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities NGS Genetic DNA Test is a groundbreaking diagnostic tool that aids in identifying genetic disorders associated with primary aldosteronism, seizures, and various neurologic abnormalities. This test utilizes Next-Generation Sequencing (NGS) technology to provide comprehensive insights into an individual’s genetic makeup, allowing for early diagnosis and tailored treatment plans.
What the Test Measures
This genetic test specifically measures alterations in the CACNA1D gene, which is crucial for calcium channel function in the body. Abnormalities in this gene can lead to significant health issues, including hormonal imbalances and neurological disorders.
Who Should Consider This Test
Individuals who may benefit from the CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities NGS Genetic DNA Test include:
- Patients with a family history of primary aldosteronism or related neurologic conditions.
- Individuals experiencing unexplained seizures or neurologic abnormalities.
- Those with symptoms of hormonal imbalances, such as hypertension.
Benefits of Taking the Test
Taking the CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities NGS Genetic DNA Test offers numerous benefits, including:
- Early detection of genetic predispositions to severe health conditions.
- Informed decision-making regarding treatment options and health management.
- Guidance for family planning and understanding hereditary risks.
Understanding Your Results
Results from the CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities NGS Genetic DNA Test will provide insights into whether any genetic alterations are present. It is important to discuss these results with a qualified healthcare provider who can offer guidance on the implications for your health and any necessary follow-up actions.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 400,000 NGN |
| Regular Price | 560,000 NGN |
Book the Test
To book the CACNA1D Gene Primary Aldosteronism Seizures and Neurologic Abnormalities NGS Genetic DNA Test, please contact us at +2348077798758 via call or WhatsApp. Our team is ready to assist you in understanding your genetic health and guiding you through the testing process.
Additional Information
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood or Extracted DNA or One drop Blood on FTA Card
Pre-Test Instructions: A clinical history of the patient is required, along with a genetic counseling session to draw a pedigree chart of family members affected with CACNA1D Gene Primary Aldosteronism, seizures, and neurologic abnormalities.
